Financials

Company Profile

Scorpius Holdings, Inc. is not engaged in any business activities. The Company was previously a contract development and manufacturing organization.

Employees

Sector

Date	Price	Change	Volume
12/06/26	0.001100 $	-90.09%	11,079
11/06/26	0.0111 $	0.00%	114,717
10/06/26	0.0111 $	+909.09%	23,276
09/06/26	0.001100 $	-21.43%	33,438

Delayed Quote OTC Markets

Market Closed - OTC Markets Other stock markets 17:29:00 12/06/2026 BST			5-day change	1st Jan Change
0.001100 ^USD	-90.09%		-21.43%	+450.00%

04-24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
04-08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI

04-24	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
04-08	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI
03-10	Scorpius Holdings, Inc. announced that it has received $0.031175 million in funding	CI
02-25	Scorpius Holdings, Inc. announced that it has received $0.219544 million in funding	CI
02-17	Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
02-11	Scorpius Holdings, Inc. announced that it has received $0.030427 million in funding	CI
01-12	Scorpius Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
12-15	Scorpius Holdings, Inc. announced that it has received $0.044374 million in funding	CI
12-10	Velocity Bioworks, Inc. acquired All of Personal Property and Assets of Scorpius Holdings, Inc. for $16.3 million.	CI
12-02	Scorpius Holdings, Inc. Announces Issuance of Multiple Non-Convertible Promissory Notes with Customary Terms	CI
11-30	Scorpius Holdings, Inc. announced that it has received $0.1541 million in funding	CI
11-25	Scorpius Holdings, Inc. announced that it has received $0.724523 million in funding	CI
11-24	Scorpius Holdings, Inc. announced that it has received $0.03795 million in funding	CI

01/05/23	Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	MT
03/04/23	Maxim Downgrades NightHawk Biosciences to Hold From Buy	MT
18/03/22	B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	MT
15/03/22	Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	MT
24/01/22	B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	MT

01-12	Scorpius : Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)	PU
14/11/24	Scorpius : Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability Form 8 K	PU
22/10/24	Scorpius Holdings Announces Partnership with U.S. Biotech Company	AQ
02/10/24	Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats	AQ
30/09/24	Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities	AQ

Manager	Title	Age	Since
Jeff Wolf CEO	Chief Executive Officer	63	31/03/2010
Joe Payne COO	Chief Operating Officer	-	-
David Waldman IRC	Investor Relations Contact	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/05/24	Jeff Wolf	Free	Chief Executive Officer	5,000,000	13.8766%
15/05/24	Seed-One Ventures LLC	Other	Company	0	0%
15/05/24	Orion Holdings LLC	Other	Company	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCORPIUS HOLDINGS, INC.	-90.09%	-21.43%	-97.50%	-100.00%	67.26K
FACTORIAL ENERGY INC.	-11.23%	+28.82%	-	-	1.4B
EINRIDE AB	-10.83%	0.00%	-	-	1.31B
AIR GLOBAL PLC	-1.43%	-0.14%	-	-	1.26B
CENTIEL AG	+8.96%	+36.19%	+329.41%	-64.90%	748M
ACC AVIATION HOLDINGS LTD.	-9.15%	+72.00%	+1,190.00%	+303.12%	644M
CANTOR EQUITY PARTNERS IV, INC.	-0.19%	+0.19%	-	-	590M
CHURCHILL CAPITAL CORP XI	-0.68%	-0.68%	-	-	569M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.35%	-0.09%	-	-	557M
Average	-12.78%	+13.39%	+473.97%	+46.07%	787.45M
Weighted average by Cap.	-4.47%	+12.83%	+727.27%	+105.25%